SOC 2 for Healthtech Companies

The HIPAA and SOC 2 Relationship

HIPAA and SOC 2 are separate compliance regimes with different authority structures. HIPAA is federal law enforced by HHS OCR; SOC 2 is an attestation standard maintained by the AICPA. HIPAA compliance is mandatory for covered entities and business associates; SOC 2 certification is voluntary but required by enterprise customers. Despite these structural differences, the two frameworks share significant control territory: access controls, encryption, audit logging, incident response, and vendor management are required by both. A SOC 2 readiness program that treats HIPAA-required controls as a starting point reaches the finish line faster. The practical implication: if your organization has already completed a HIPAA risk analysis, those findings directly inform your SOC 2 gap analysis. Documented HIPAA policies become the foundation for SOC 2 policy documentation with relatively minor additions. HIPAA audit log requirements map almost directly to SOC 2 Security monitoring criteria. Building your SOC 2 program on your HIPAA foundation rather than from scratch is typically thirty to fifty percent faster. Conversely, SOC 2 certification adds credibility to your HIPAA compliance program in conversations with healthcare enterprise customers, because it provides third-party independent attestation of your security controls rather than self-reported compliance status.

Protected Health Information in SOC 2 Scope

If your healthtech product stores or processes PHI, that data is in scope for your SOC 2 audit. The Confidentiality and Privacy Trust Service Criteria are most relevant. Confidentiality addresses how you protect PHI from unauthorized access; Privacy addresses how you collect, use, retain, and disclose health information. Note that the Privacy TSC is optional — you select which criteria to include in your audit scope. For healthtech companies processing PHI, adding Privacy criteria signals to healthcare enterprise buyers that your audit addressed their specific concerns. When defining your audit scope, work carefully with your auditor to enumerate every system component that stores, processes, or transmits PHI. Exclude systems with no PHI contact. The more precisely you define and defend your scope boundary, the less audit surface you need to cover and the lower your control implementation and audit costs. Document your scope rationale clearly — auditors may challenge scope exclusions if they appear to exclude high-risk systems.

BAAs, Vendor Management, and SOC 2

HIPAA requires business associate agreements with every vendor that has access to PHI. SOC 2 requires vendor risk assessments for every vendor that could affect your trust service criteria. For healthtech companies, these requirements overlap substantially. Every vendor receiving PHI needs both a BAA and a risk assessment. Build a vendor register that tracks BAA status alongside SOC 2 compliance status. Auditors will review this register during fieldwork; gaps in either category are findings. Pay special attention to cloud infrastructure vendors: AWS, Azure, and GCP all offer BAAs and have SOC 2 Type 2 reports, but you need to confirm which services are covered by each. A vendor may have a SOC 2 report but exclude specific services you rely on — read the report scope section carefully rather than assuming all services are covered. Also track subprocessors: if your primary cloud vendor uses sub-vendors to deliver services, those sub-vendors may also access your PHI and need evaluation.

De-identification as a Scope Reduction Strategy

De-identifying health data before processing or storing it can reduce both HIPAA obligations and SOC 2 scope. HIPAA provides two de-identification methods: Expert Determination and Safe Harbor. Properly de-identified data is not PHI and falls outside HIPAA scope. For SOC 2, scope reduction is always preferable when technically feasible. If your analytics or AI product can operate on de-identified data, the architectural decision to de-identify at ingestion dramatically simplifies your compliance posture. Weigh this option early — retrofitting de-identification is expensive. When evaluating the Safe Harbor method, be aware that the eighteen HIPAA identifiers that must be removed include fields that seem innocuous in isolation but can be re-identifying in combination. Date elements (other than year), geographic subdivisions smaller than state, and ages over eighty-nine are common Safe Harbor failure points. If Expert Determination is your chosen method, retain a statistician with documented credentials to certify the de-identification and preserve that certification as compliance evidence.

Availability Requirements for Healthcare Products

Healthcare enterprise customers often have contractual uptime requirements tied to patient care workflows. EHR integrations, clinical decision support, and patient communication tools may be on critical care paths. Your SOC 2 Availability criteria documentation must reflect actual SLA commitments. Monitor uptime continuously during your observation period — downtime events require incident documentation and root cause analysis. Healthcare auditors are particularly attentive to availability because downtime in clinical settings has patient safety implications. Define your availability metrics precisely in your SLA documentation: distinguish between scheduled maintenance windows and unplanned downtime, specify whether your SLA covers calendar month or rolling period measurement, and document how downtime is measured (synthetic monitoring, real user monitoring, or infrastructure health checks). Auditors will ask you to demonstrate that your monitoring system would have detected downtime events that occurred during the observation period. Ensure your monitoring coverage is comprehensive — gaps in monitoring are as much of a finding as actual downtime. If your product is on clinical workflows with zero-tolerance downtime requirements, document your degraded-mode capabilities: what can users still do when your service is partially unavailable? Graceful degradation and clear user communication during incidents are control evidence that demonstrates operational maturity to healthcare auditors.

From the Founder: The Attestation Letter That Closed a Healthcare Deal

Most healthtech founders waiting on their first SOC 2 Type 2 report assume enterprise health-system deals are blocked until the report lands. They are not. Two months into our three-month Type 2 observation period at my prior company, a healthcare prospect needed proof that we were certified. We did not have a report yet — we were not even at the end of the observation window. I asked our CPA firm somewhat nervously if they could provide anything. They sent a signed letter of attestation on firm letterhead within an hour, confirming that we were actively undergoing a SOC 2 Type 2 audit from a specific start date to a specific end date. No findings, no detailed control documentation — just proof that we had committed to the process and a professional auditor was watching. That letter closed the deal. The deeper lesson for healthtech specifically: health-system procurement teams are managing their own regulatory exposure (HIPAA, HITRUST, state breach notification laws). They are not asking for your SOC 2 report because they enjoy paperwork. They are asking because their compliance officer needs documentation to approve the vendor relationship. An attestation letter answers their actual question — "is this vendor seriously in audit?" — without requiring a finished report. Engage your auditor early, ask for the attestation letter the day your observation period starts, and use it as a sales tool while your report is in progress. We also seriously evaluated a HIPAA-focused compliance platform at three hundred ninety-nine dollars per month that covered policies, risk assessments, vendor risk management, and employee training. Even that price did not justify itself once we were already paying a CPA firm for the actual audit — the bottleneck for our small team was never tooling cost. It was the discipline of maintaining the cadence we had declared in our policies for twelve straight months. For deeper context on the cost realities of SOC 2 for small healthtech teams, see our breakdown of why [enterprise GRC platforms are overkill for seed-stage startups](/blog/enterprise-grc-overkill-startups) and our take on [skipping Type 1 entirely to save fifteen to twenty thousand dollars](/blog/skip-soc2-type1).

Preparing for a Healthtech SOC 2 Audit

Healthtech audits typically require more documentation than standard SaaS audits. Prepare for detailed evidence requests around: PHI access logs and access reviews, encryption configuration for data at rest and in transit, BAA records for all PHI-handling vendors, incident response records including any security events during the observation period, and employee training records covering both security awareness and HIPAA privacy training. If your product integrates with EHR systems via HL7 FHIR or similar standards, document your integration architecture and the data elements transmitted. Organize your evidence in a logical structure before fieldwork begins: group evidence by control area, label each artifact with the control it satisfies, and prepare a brief narrative explaining how each piece of evidence demonstrates control effectiveness. Auditors who receive well-organized evidence packages complete fieldwork faster and generate fewer clarifying questions. This directly reduces the time your team spends on the audit and accelerates report delivery. For FHIR-integrated products specifically, document which FHIR resources your application reads and writes, which SMART on FHIR scopes you request, and how you validate OAuth tokens from the EHR authorization server. Auditors reviewing healthtech companies with EHR integrations increasingly ask for this level of technical detail.

SOC 2 Readiness Roadmap for Healthtech Companies

Healthtech companies entering SOC 2 for the first time should plan for a twelve-month journey from program launch to report delivery. The first two months focus on gap assessment and scoping: work with your auditor to define which trust service criteria to include, map your current controls to each criterion, and identify gaps. Healthtech companies typically find their largest gaps in access management (too many people with PHI access who no longer need it), vendor management (missing BAAs or stale risk assessments), and incident response (procedures exist but have never been tested). Months three through five focus on control implementation: close your access management gaps with quarterly access reviews, update your vendor register, execute a tabletop incident response exercise and document the results, and implement technical controls like automated PHI access logging if not already in place. Months six through eleven are your observation period: maintain all controls consistently and collect evidence systematically. In month twelve, support audit fieldwork. After your first report, renewal is significantly easier — your controls are established, your evidence collection habits are ingrained, and your team knows the audit process. Budget ninety days for a Type 1 report (from engagement start to report delivery) if you need to unblock a specific deal before your Type 2 observation period completes. Align your SOC 2 renewal cycle with your HIPAA risk analysis schedule: both should occur annually, and conducting them in the same quarter reduces the total staff time required by sharing the gap assessment and vendor review work.

Running HIPAA and SOC 2 Programs Efficiently Together

The biggest efficiency gain for healthtech companies is building a unified control framework that satisfies both HIPAA and SOC 2 requirements simultaneously. Start by mapping HIPAA Security Rule requirements to SOC 2 Trust Service Criteria. Most HIPAA administrative safeguards (risk analysis, workforce training, access management policies) map directly to SOC 2 Security criteria. Most HIPAA technical safeguards (access controls, audit controls, encryption) map to SOC 2 Confidentiality and Security criteria. Build controls that satisfy both sets of requirements and document them in a unified policy library. Maintain a single evidence collection process that captures artifacts relevant to both programs. This unified approach typically reduces your total compliance workload by thirty to forty percent compared to running separate programs. It also simplifies vendor conversations: when a healthcare enterprise partner asks about both your HIPAA compliance and your SOC 2 certification, you can answer from a single integrated program rather than describing two parallel efforts. SimpleAudit supports this unified approach through its AI policy generator, which produces policies that address compliance overlaps across multiple frameworks. The unified framework also simplifies your security team hiring and onboarding: a single program with clear ownership is easier to transfer to a new compliance lead than two separate programs with partially overlapping documentation stored in different systems.

Related Resources

• SOC 2 Compliance Guide
• SOC 2 vs HIPAA Comparison
• Skip SOC 2 Type 1 (attestation letter tactic)
• Enterprise GRC Platforms Are Overkill for Seed-Stage Startups
• SOC 2 When Nobody on Your Team Is a Security Person

Frequently Asked Questions